Celgene Reports Second Quarter 2019 Operating and Financial Results
Go back to Celgene Reports Second Quarter 2019 Operating and Financial Results| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 67.61 +1.56 (2.36%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $66.05 | 52 Week High | $77.12 | |||
| Open | $66.80 | 52 Week Low | $49.03 | |||
| Day High | $68.64 | P/E | 43.90 | |||
| Day Low | $66.61 | EPS | $1.54 | |||
| Volume | 13,898,733 | |||||
| Celgene Corp. (NASDAQ: CELG) | Delayed: 108.24 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $108.24 | 52 Week High | $127.00 | |||
| Open | $7.85 | 52 Week Low | $93.05 | |||
| Day High | $108.24 | P/E | 32.12 | |||
| Day Low | $108.24 | EPS | $3.37 | |||
| Volume | 0 | |||||
